The ECO Animal Health sheep vaccine licence sent shares in the AIM-quoted veterinary group up as much as 6.3% on Wednesday, while Bravura Solutions posted its full-year results and 80 Mile disclosed a drilling delay in Greenland.
ECO Animal Health Sheep Vaccine: Licence Terms and Peak Sales
ECO Animal Health (LON: EAH) said it had in-licensed a late-stage sheep toxoplasmosis vaccine from Vaxinano SAS. The licence is perpetual and exclusive, covering all key commercial sheep markets globally, with the underlying technology carrying patent protection, according to VetClick reporting on the announcement.
Annual peak sales in Europe could reach £10m, with the UK the largest potential market. The company said the vaccine can be commercialised through its existing marketing structure, with investment funded from operating cashflow in line with existing R&D plans.
Under the Alliance News account of the deal terms, ECO Animal Health will pay Vaxinano a modest upfront licence fee, a future development milestone payment, and future royalties on commercial sales. An existing vaccine is on the market, but ECO said it has drawbacks.
Prior to this agreement, ECO Animal Health had launched a proprietary poultry vaccine in the EU in July 2026, according to Kalkine Media.
The ECO Animal Health sheep vaccine announcement pushed shares to 102.5p, a gain of 5.67%, by one intraday snapshot. Alliance News via LSE.co.uk recorded a slightly higher move of 6.3% to 103.15p, reflecting a different point in the session.
Five analysts tracked by Investing.com UK carry a consensus ‘Strong Buy’ rating on EAH, with an average 12-month price target of 173.4p, a high estimate of 257p and a low of 136p.
Bravura Posts FY26 Revenue and Profit Growth
Bravura Solutions (LON: BVS), which recently joined AIM, reported FY26 underlying revenues of $282.6m and underlying net profit after tax of $63.1m. The company also announced a share buyback alongside its results on 12 August 2026, according to Investing.com Canada.
Recurring revenue reached $165.0m, up 6.9% year-on-year, per reporting on the company’s results announcement. Underlying Cash EBITDA came in at $77.1m, representing a 27.3% margin.
Cash at end of June 2026 was $50.3m, with unused debt facilities of up to $100m. Bravura declared a final dividend of 8.31 cents per share and a special dividend of 6.69 cents per share. The shares closed up 13.9% at 163.5p, the strongest performance among Wednesday’s AIM movers.
Kazera, Buccaneer and Wednesday’s Fallers
Kazera Global (LON: KZG) said its subsidiary Whale Head Minerals, in which Kazera holds a 70% direct beneficial interest, has prepared an interim operational plan for its heavy mineral sands project in Alexander Bay, South Africa. The plan targets a progressive ramp-up to 30,000 tonnes per month, against an earlier programme launched in February 2026 that was targeting more than 4,000 tonnes per month, per a prior operational update. Production could start in early 2027. Shares rose 6.67% to 1.6p.
Buccaneer Energy (LON: BUCE) raised £460,000 at 0.01p per share, split between £319,000 in cash and £141,000 of fees paid in shares, to fund a push into European onshore gas. The company has screened more than 300 opportunities and is preparing a shortlist. Operations in Texas continue to generate cash, and the three-to-five-year target is production of 5,000 barrels of oil equivalent per day. Shares gained 5.26% to 0.01p.
Among fallers, 80 Mile (LON: 80M) slumped 20.9% to 0.489p after disclosing that drilling on its Jameson Land Basin project in East Greenland has been delayed by permitting and regulatory approvals. Drilling is now expected in winter 2027. The company also received a formal warning from authorities for landing equipment without permission.
Titon Holdings (LON: TON) fell 10.5% to 85p after broker Shore cut its revenue forecast from £18.3m to £17m, though that compares with £15.8m last year. Delays to mechanical ventilation projects pushed activity into the next financial year, and Shore now expects a full-year loss. Cash was £2.2m at end of July 2026.
Celsius Resources (LON: CLA) slipped 9.09% to 0.25p after a Temporary Order of Protection was granted by the Regional Trial Court of Makati City, preventing Equinaire from proceeding with foreclosure on Celsius’s stake in Makilala Mining Company Inc. The order lasts until 25 August 2026. Celsius plans to start arbitration proceedings.
Galantas Gold (LON: GAL) eased 2.04% to 24p after selecting M3 Engineering and Technology to lead a preliminary economic assessment for relocating a crushing plant to the Andacollo gold project in Chile. The assessment could complete before year-end, with production potentially restarting in the first quarter of 2027.
